Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Aug;29(2):240–246.

Comparative study of delayed hypersensitivity skin reactions and antibodies to human papilloma (HPV)

J Viac, J Thivolet, M R Hegazy, Y Chardonnet, C Dambuyant
PMCID: PMC1541088  PMID: 198169

Abstract

Purified human papilloma virus (HPV) was prepared from plantar warts, inactivated by formalin, adjusted to 1010 particles per 0·1 ml and used in intradermal tests (IDT) on 120 patients having warts at that time, or having had warts in the past, together with sixty-three controls. Antibodies were evaluated in the sera from most of the patients by the indirect immunofluorescence (IF) test before and after the skin tests. The results showed a specific delayed-hypersensitivity reaction (DHR) to HPV, especially in patients with `regressing' or `past' warts (76%). DHR was most frequent in patients with a wart of 6 months–2 years duration (77·0–68·8%) and persisted much longer than antibodies, which disappeared with the passage of time. The incidence of antibodies was much higher after IDT in patients with a positive reaction, thus suggesting a booster effect.

Full text

PDF
240

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C. Cell-mediated immune responses to virus infections and virus-induced tumours. Br Med Bull. 1967 Jan;23(1):60–65. doi: 10.1093/oxfordjournals.bmb.a070518. [DOI] [PubMed] [Google Scholar]
  2. Almeida J. D., Goffe A. P. Antibody to wart virus in human sera demonstrated by electron microscopy and precipitin tests. Lancet. 1965 Dec 11;2(7424):1205–1207. doi: 10.1016/s0140-6736(65)90633-1. [DOI] [PubMed] [Google Scholar]
  3. Cubie H. A. Serological studies in a student population prone to infection with human papilloma virus. J Hyg (Lond) 1972 Dec;70(4):677–690. doi: 10.1017/s0022172400022531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Genner J. Localization of wart virus antigen in human plantar warts (verrucae vulgares). Acta Derm Venereol. 1971;51(5):361–364. [PubMed] [Google Scholar]
  5. Greenberg J. H., Smith T. L., Katz R. M. Verrucae vulgaris rejection. A preliminary study of contact dermatitis and cellular immunity response. Arch Dermatol. 1973 Apr;107(4):580–582. doi: 10.1001/archderm.107.4.580. [DOI] [PubMed] [Google Scholar]
  6. Hellström I., Evans C. A., Hellström K. E. Cellular immunity and its serum-mediated inhibition in Shope-virus-induced rabbit papillomas. Int J Cancer. 1969 Sep 15;4(5):601–607. doi: 10.1002/ijc.2910040504. [DOI] [PubMed] [Google Scholar]
  7. Ivanyi L., Morison W. L. In vitro lymphocyte stimulation by wart antigen in man. Br J Dermatol. 1976 May;94(5):523–527. doi: 10.1111/j.1365-2133.1976.tb05140.x. [DOI] [PubMed] [Google Scholar]
  8. KREIDER J. W. STUDIES ON THE MECHANISM RESPONSIBLE FOR THE SPONTANEOUS REGRESSION OF THE SHOPE RABBIT PAPILLOMA. Cancer Res. 1963 Oct;23:1593–1599. [PubMed] [Google Scholar]
  9. Lee K. P., Olson C. Precipitin response of cattle to bovine papilloma virus. Cancer Res. 1969 Jul;29(7):1393–1397. [PubMed] [Google Scholar]
  10. Lee K. P., Olson C. Response of calves to intravenous and repeated intradermal inoculation of bovine papilloma virus. Am J Vet Res. 1968 Nov;29(11):2103–2112. [PubMed] [Google Scholar]
  11. Matthews R. S., Shirodaria P. V. Study of regressing warts by immunofluorescence. Lancet. 1973 Mar 31;1(7805):689–691. doi: 10.1016/s0140-6736(73)91478-5. [DOI] [PubMed] [Google Scholar]
  12. Ogilvie M. M. Serological studies with human papova (wart) virus. J Hyg (Lond) 1970 Sep;68(3):479–490. doi: 10.1017/s0022172400042388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Pass F., Marcus D. M. Wart-associated antigens. I. Isolation of tissue antigens using antibody immunoadsorbents. J Invest Dermatol. 1973 May;60(5):301–305. [PubMed] [Google Scholar]
  14. Pyrhönen S., Penttinen K. Wart-virus antibodies and the prognosis of wart disease. Lancet. 1972 Dec 23;2(7791):1330–1332. doi: 10.1016/s0140-6736(72)92776-6. [DOI] [PubMed] [Google Scholar]
  15. Reid T. M., Fraser N. G., Kernohan I. R. Generalized warts and immune deficiency. Br J Dermatol. 1976 Nov;95(5):559–564. doi: 10.1111/j.1365-2133.1976.tb00870.x. [DOI] [PubMed] [Google Scholar]
  16. Rowson K. E., Mahy B. W. Human papova (wart) virus. Bacteriol Rev. 1967 Jun;31(2):110–131. doi: 10.1128/br.31.2.110-131.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Spencer E. S., Andersen H. K. Clinically evident, non-terminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft recipients. Br Med J. 1970 Aug 1;3(5717):251–254. doi: 10.1136/bmj.3.5717.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stevens D. A., Ferrington R. A., Merigan T. C., Marinkovich V. A. Randomized trial of transfer factor treatment of human warts. Clin Exp Immunol. 1975 Sep;21(3):520–524. [PMC free article] [PubMed] [Google Scholar]
  19. Tagami H., Ogino A., Takigawa M., Imamura S., Ofuji S. Regression of plane warts following spontaneous inflammation. An histopathological study. Br J Dermatol. 1974 Feb;90(2):147–154. doi: 10.1111/j.1365-2133.1974.tb06378.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES